The largest incidence of testicular cancer is in countries of the Northern Europe, particularly Denmark. Testicular cancer is typical in younger and middle-aged men, it rarely occurs in men aged above 50. According to US research studies there is a close link between testicular cancer and male infertility.
Testicular cancer is common in young men aged below 35. In 90% of cases it occurs in Caucasians and frequently in Nordic countries. Risk factors include testicular infections, reduced immune function and developmental defects such as cryptorchidism – undescended testis. A higher risk is in men who have undergone an intervention for this.
Signs and symptoms
Most symptoms may be caused by other benign testicular diseases, but their occurrence should not be underestimated and a medical help should be sought, particularly if problems last longer than 14 days. The most common sign is a change to the size of the testicle, pain, swelling and redness, or the presence of lumps in the scrotum. Pain in the lower abdomen may appear, and increased sensitivity or enlargement of nipples is also common.
Preventing testicular cancer
Prevention is impossible; however, a self-exam and reinforcement of the immune system may help to detect the disease early.
Impact of the immune system on testicular cancer
It is possible to alleviate or limit the risk factors of testicular cancer with the immune system boost. A strong immunity destroys cancer cells and protects male gonads against the disease. If any testicular cancer symptoms are identified, a timely intervention may be provided using natural products enhancing immunity. Even in a case of a benign testicular disease immunity should be promoted.
Studies - oncological diseases
Types of cancer
Liver cancer, Brain cancer, Hodgkin´s lymphoma, Cervical cancer, Kidney cancer, Leukemia, Lung cancer, Skin cancer, Uterine cancer, Prostate cancer, Breast cancer, Pancreatic cancer, Colon cancer, Bladder cancer, Ovarian cancer, Testicular cancer, Stomach cancer, Oesophageal cancer, Thymus cancer, Thyroid cancer